A $4 antidepressant available generically might be a “game changer” in COVID treatment for certain types of high-risk patients, a new study has found.
The study also revealed that Americans are overwhelmingly unaware of new legislation touted by democratic lawmakers as a milestone victory i...
No comments:
Post a Comment